| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 189,750 | 182,567 | 180,212 | 200,310 | | Cost of Revenue | 152,267 | 140,886 | 132,128 | 171,728 | | | Gross Profit | 37,483 | 41,681 | 48,084 | 28,582 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,155 | 24,115 | 23,515 | 20,411 | | Non Recurring | (3) | (4) |
-
| 6 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,331 | 17,570 | 24,569 | 8,165 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (234) | 5,137 | (204) | 184 | | Earnings Before Interest And Taxes | 11,097 | 22,707 | 24,365 | 8,349 | | Interest Expense | 3,759 | 3,945 | 4,348 | 3,820 | | Income Before Tax | 7,338 | 18,762 | 20,017 | 4,529 | | Income Tax Expense | 1,921 | 7,192 | 7,892 | (5,183) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,417 | 11,570 | 12,125 | 9,712 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (199) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,417 | 11,570 | 12,125 | 9,513 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,417 | $11,570 | $12,125 | $9,513 |
|
0.51% Nasdaq 
Income Statement
